809 research outputs found
Short term prediction of E greater than or equal to 10 MeV proton fluxes from solar flares
Both the anisotropic and isotropic diffusion theories can be used to extrapolate proton fluxes for E greater than or equal to 10 meV for over 50% of the particle events. The isotropic diffusion theory uses a diffusion coefficient: D = Mr sup beta. It was found that M and beta tended to be functions of flare position on the solar disk. A measurement of the interplanetary flux in near earth space gives a good indication of the polar cap fluxes. It was found that the 30 MHz absorption over the poles during a PCA is proportional to the square root of the integral proton flux E greater than or equal to 11 meV in interplanetary space, J = KA squared, with K = 8 plus or minus 2 and J in protons/sq cm-sec-ster
Transcatheter Implantation of the MONARC Coronary Sinus Device for Mitral Regurgitation 1-Year Results From the EVOLUTION Phase I Study (Clinical Evaluation of the Edwards Lifesciences Percutaneous Mitral Annuloplasty System for The Treatment of Mitral Regurgitation)
ObjectivesThis study sought to assess the safety and efficacy of transcatheter valve annuloplasty in patients with mitral regurgitation (MR).BackgroundMitral regurgitation is associated with a worsened prognosis in patients with dilated cardiomyopathy. Surgical mitral annuloplasty reduces the septal-lateral dimension of the mitral annulus resulting in improved leaflet coaptation with a reduction in regurgitation. Percutaneous annuloplasty with the MONARC device (Edwards Lifesciences, Irvine, California) implanted within the coronary sinus is designed to reduce mitral regurgitation through a similar mechanism.MethodsA total of 72 patients with MR grade ā„2 were enrolled at 8 participating centers in 4 countries. Clinical evaluation and transthoracic echocardiography were performed at baseline and at 3, 6, and 12 months. Multislice cardiac computed tomography and coronary angiography were performed at baseline and 3 months.ResultsThe MONARC device was implanted in 59 of 72 patients (82%). The primary safety end point (freedom from death, tamponade, or myocardial infarction at 30 days) was met in 91% of patients at 30 days and in 82% at 1 year. Computed tomography imaging documented passage of the great cardiac vein over an obtuse marginal artery in 55% of patients and was associated with angiographic coronary artery compression in 15 patients and myocardial infarction in 2 patients (3.4%). At 12 months, a reduction in MR by ā„1 grade was observed in 50.0% of 22 implanted patients with matched echocardiograms and in 85.7% of 7 patients with baseline MR grade ā„3.ConclusionsImplantation of the MONARC device in the coronary sinus is feasible and may reduce MR. However, coronary artery compression may occur in patients in whom the great cardiac vein passes over a coronary artery, necessitating strategies in future studies to avoid this occurrence
The Use of Radiofrequency Energy in Pediatric Cardiology
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/73038/1/j.1540-8183.1995.tb00583.x.pd
Managing patients with ICD shocks and programming tachycardia therapies during acute heart failure syndromes
We review the pharmacologic, interventional and device programming treatment options for patients with implantable cardioverter-defibrillators who present with acute heart failure and implantable cardioverter-defibrillator shocks
Should mechanical dyssynchrony be assessed in patients with implantable cardioverter-defibrillators?
Cardiac Dysfunction and Arrhythmia
- ā¦